Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback